4.6 Article

Multicenter Validation of a Urine CXCL10 Assay for Noninvasive Monitoring of Renal Transplants

Related references

Note: Only part of the references are listed.
Editorial Material Surgery

T cell-mediated rejection in kidney transplant recipients: The end(point) is also the beginning

Sindhu Chandran et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Surgery

The negative impact of T cell-mediated rejection on renal allograft survival in the modern era

Christie Rampersad et al.

Summary: The study shows that in kidney transplant recipients receiving tacrolimus/mycophenolate-based maintenance therapy, TCMR is common, correlates with HLA-DR/DQ molecular mismatch scores, and is associated with the risk of graft loss.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Review Surgery

Effectiveness of T cell-mediated rejection therapy: A systematic review and meta-analysis

Julie Ho et al.

Summary: This study analyzed the effectiveness of T cell-mediated rejection therapy in patients on tacrolimus and mycophenolic acid, showing that 39% of patients continued to have rejection after treatment. Pulse steroids and augmented maintenance immunosuppression were commonly used, but there was considerable practice heterogeneity.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Editorial Material Surgery

Revisiting acute T cell-mediated rejection in kidney allografts

Ilkka Helantera et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Surgery

Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients

Tom D. Blydt-Hansen et al.

Summary: Urinary CXCL10/Cr immune monitoring is useful for real-time clinical monitoring in children, predicting rejection risk, immune quiescence, and allograft function decline. Serial urine samples can anticipate rejection up to 4 weeks prior to biopsy and decline within 1 month following treatment.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Transplantation

Technical Considerations and Confounders for Urine CXCL10 Chemokine Measurement

Joelle Handschin et al.

TRANSPLANTATION DIRECT (2020)

Editorial Material Surgery

The special relativity of noninvasive biomarkers for acute rejection

Maarten Naesens

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

Review Immunology

Activity-based Protein Profiling Approaches for Transplantation

Mario Navarrete et al.

TRANSPLANTATION (2019)

Editorial Material Surgery

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report

Anat R. Tambur et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

Article Surgery

T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts

Carmen Lefaucheur et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

Article Computer Science, Interdisciplinary Applications

lmerTest Package: Tests in Linear Mixed Effects Models

Alexandra Kuznetsova et al.

JOURNAL OF STATISTICAL SOFTWARE (2017)

Article Multidisciplinary Sciences

A comprehensive analysis and annotation of human normal urinary proteome

Mindi Zhao et al.

SCIENTIFIC REPORTS (2017)

Article Medical Laboratory Technology

Multicenter Evaluation of Cystatin C Measurement after Assay Standardization

Anne -Sophie Bargnoux et al.

CLINICAL CHEMISTRY (2017)

Article Immunology

Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome

Patricia Hirt-Minkowski et al.

TRANSPLANTATION (2016)

Article Transplantation

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10

Julie Ho et al.

TRANSPLANTATION DIRECT (2016)

Article Computer Science, Interdisciplinary Applications

Fitting Linear Mixed-Effects Models Using lme4

Douglas Bates et al.

JOURNAL OF STATISTICAL SOFTWARE (2015)

Article Urology & Nephrology

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients

Donald E. Hricik et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Urology & Nephrology

Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection

Marion Rabant et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Transplantation

Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels

Patricia Hirt-Minkowski et al.

TRANSPLANTATION DIRECT (2015)

Article Surgery

Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury

D. E. Hricik et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2013)

Article Medicine, General & Internal

Urinary-Cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts

Manikkam Suthanthiran et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, Research & Experimental

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

Armanda Casrouge et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Medical Laboratory Technology

First certified reference material for cystatin C in human serum ERM-DA471/IFCC

Anders Grubb et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)

Article Surgery

Urinary CXCL9 and CXCL10 Levels Correlate with the Extent of Subclinical Tubulitis

S. Schaub et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

Article Surgery

Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction

HZ Hu et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2004)